These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12417536)

  • 1. Cardiology patient pages. Hypertrophic cardiomyopathy.
    Maron BJ
    Circulation; 2002 Nov; 106(19):2419-21. PubMed ID: 12417536
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of hypertrophic cardiomyopathy.
    Enriquez AD; Goldman ME
    Ann Glob Health; 2014; 80(1):35-45. PubMed ID: 24751563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiology patient page. Hypertrophic cardiomyopathy: a patient perspective.
    Nishimura RA; Ommen SR; Tajik AJ
    Circulation; 2003 Nov; 108(19):e133-5. PubMed ID: 14609998
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary prevention of sudden cardiac death in a low-risk child with familial hypertrophic cardiomyopathy: the role of cardiac magnetic resonance imaging.
    Yamazawa H; Takeda A; Takei K; Furukawa T
    Clin Res Cardiol; 2014 Jan; 103(1):75-7. PubMed ID: 24170035
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypertrophic cardiomyopathy at 50.
    Yacoub M; Olivotto I; Cecchi F
    J Cardiovasc Transl Res; 2009 Dec; 2(4):339-40. PubMed ID: 20559992
    [No Abstract]   [Full Text] [Related]  

  • 6. [Alcohol septal ablation and prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy. A case report].
    Ardashev AV; Shavarov AA; Dzhandzhgava AO; Rybachenko MS; Kriuchko MIu
    Kardiologiia; 2009; 49(6):72-9. PubMed ID: 19656099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Malignant form of familial hypertrophic cardiomyopathy complicated with ventricular fibrillation in siblings. Electrocardiogram in hypertrophic cardiomyopathy - a review].
    Kukla P; Petkow-Dimitrow P; Jastrzebski M; Bednarek J; Lelakowski J; Bryniarski L
    Kardiol Pol; 2009 Jul; 67(7):774-80; discussion 781. PubMed ID: 19650001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnosis and treatment of hypertrophic cardiomyopathy.
    Prinz C; Farr M; Hering D; Horstkotte D; Faber L
    Dtsch Arztebl Int; 2011 Apr; 108(13):209-15. PubMed ID: 21505608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A contemporary approach to hypertrophic cardiomyopathy.
    Ho CY; Seidman CE
    Circulation; 2006 Jun; 113(24):e858-62. PubMed ID: 16785342
    [No Abstract]   [Full Text] [Related]  

  • 10. Device therapy in hypertrophic cardiomyopathy.
    Beadle R; Williams L
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1767-75. PubMed ID: 21108558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of hypertrophic cardiomyopathy - the most common inherited heart disease].
    Magnusson P; Gadler F; Mörner S
    Lakartidningen; 2018 Jun; 115():. PubMed ID: 29893985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When the heart in trouble is a young one.
    Dulak SB
    RN; 2006 May; 69(5):24ac1-5; quiz 24ac6. PubMed ID: 16722262
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk stratification in hypertrophic cardiomyopathy: time for renewal?
    Pacileo G; Salerno G; Gravino R; Calabrò R; Elliott PM
    J Cardiovasc Med (Hagerstown); 2013 May; 14(5):319-25. PubMed ID: 22885536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention.
    Olde Nordkamp LR; Wilde AA; Tijssen JG; Knops RE; van Dessel PF; de Groot JR
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):91-100. PubMed ID: 23275262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of familial hypertrophic cardiomyopathy: from mutation to bedside.
    Brouwer WP; van Dijk SJ; Stienen GJ; van Rossum AC; van der Velden J; Germans T
    Eur J Clin Invest; 2011 May; 41(5):568-78. PubMed ID: 21158848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragmented QRS predicts heart failure progression in patients with hypertrophic cardiomyopathy.
    Nomura A; Konno T; Fujita T; Tanaka Y; Nagata Y; Tsuda T; Hodatsu A; Sakata K; Nakamura H; Kawashiri MA; Fujino N; Yamagishi M; Hayashi K
    Circ J; 2015; 79(1):136-43. PubMed ID: 25381793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can an athlete have too much ticker? Hypertrophic cardiomyopathy in young athletes.
    Fitzgerald NM; Sherwood M; Fitzgerald DA
    J Paediatr Child Health; 2012 Oct; 48(10):E156-60. PubMed ID: 22846097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress in end-stage hypertrophic cardiomyopathy.
    Xiao Y; Yang KQ; Jiang Y; Zhou XL
    Am J Med Sci; 2015 May; 349(5):448-53. PubMed ID: 25901536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dimensional analysis of HRV in hypertrophic cardiomyopathy patients.
    Carvajal R; Zebrowski JJ; Vallverdú M; Baranowski R; Chojnowska L; Poplawska W; Caminal P
    IEEE Eng Med Biol Mag; 2002; 21(4):71-8. PubMed ID: 12222120
    [No Abstract]   [Full Text] [Related]  

  • 20. Familial Hypertrophic Cardiomyopathy: Diagnosis and Management.
    Litt MJ; Ali A; Reza N
    Vasc Health Risk Manag; 2023; 19():211-221. PubMed ID: 37050929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.